Zhuang Renxiang: Moderna’s next-generation vaccine will be available in mid-September if it passes EUA

The UK is the first in the world to approve the Moderna next-generation vaccine, which can fight both the Wuhan strain and the BA.1 variant. Command center spokesman Zhuang Renxiang said today that the Food and Drug Administration is reviewing the EUA.

The UK is the first in the world to approve the Moderna next-generation vaccine, which can fight both the Wuhan strain and the BA.1 variant. Command center spokesman Zhuang Renxiang said today that the Food and Drug Administration is reviewing the EUA.  (Central News Agency file photo)

The UK is the first in the world to approve the Moderna next-generation vaccine, which can fight both the Wuhan strain and the BA.1 variant. Command center spokesman Zhuang Renxiang said today that the Food and Drug Administration is reviewing the EUA. (Central News Agency file photo)

The domestic new crown pneumonia epidemic has not stopped, and the Omicron BA.5 sub-variant virus epidemic has hit the world once more. The United Kingdom has recently become the first country in the world to approve the use of Moderna’s next-generation vaccine. When will Taiwan review the next-generation vaccine? focus on. Zhuang Renxiang, a spokesman for the Central Epidemic Command Center, said at a press conference on the epidemic in the followingnoon that the next-generation vaccine approved by the United Kingdom is a bivalent vaccine, which includes the original Wuhan strain and the Omicron BA.1 vaccine strain. The country is expected to approve the use one following another, and Modena also simultaneously sends the review materials to the Food and Drug Administration for rolling review.

However, he said that it is known that the United States insists on waiting for another next-generation vaccine using the BA.5 variant in Moderna, so it has not approved the emergency use authorization (EUA) of this vaccine; the second-generation vaccine containing BA.5 Generation vaccines are still undergoing relevant trials and should wait a while longer.

As for whether Taiwan will follow in the footsteps of the United Kingdom and approve this next-generation vaccine containing the BA.1 vaccine strain? Zhuang Renxiang pointed out that this matter is related to vaccine policy, and factors such as the possibility that the epidemic will heat up in the following August and September must be taken into account. If Taiwan approves the EUA before September, the first batch of next-generation vaccines is expected to be available in mid-September at the earliest. . As for the progress and speed of the FDA’s review, Zhuang Renxiang did not comment.

According to the statistics of the command center, a total of 2,085 doses of Moderna’s infant vaccine were vaccinated yesterday, with a total of 133,481 doses, a coverage rate of 17.1%; a total of 60,122,960 doses of domestic new coronary pneumonia vaccines were vaccinated, with a population coverage rate of 92.2% for the first dose and 92.2% for the first dose. 86.2% for 2 doses, 0.8% for basal booster, 71.7% for booster, and 8.3% for the second booster.

Responsible editor: Yu Weining

The latest local epidemic
China added 22,902 local cases and 16 deaths, the lowest in 97 days
BA.5 broke 80,000 cases so fierce?Zhuangren Xiangxiu’s latest estimate
Epidemic resurgence, doctors pierce the fantasy of mask-free: the new crown will not become flu
The pilots union said that the crew members can only wait for the hotel to wait for the command center to respond.
Do you have to wear N95 when BA.5 comes?Intensive care doctor: the general public can choose “this”

Related news video

Share:

Facebook
Twitter
Pinterest
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.